Organization Overview
Alternative names
acetylsalicylic acid (aspirin) (1 trial)
aluminum chlorohydrate (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
autologous hematopoietic stem cells (3 trials)
bacille calmette-guerin (3 trials)
bendamustine (treanda) (2 trials)
bevacizumab (avastin) (6 trials)
capecitabine (xeloda) (13 trials)
carboplatin (paraplatin) (6 trials)
cladribine (leustatin) (2 trials)
cyclophosphamide (cytoxan) (7 trials)
cyclosporine (sandimmune) (1 trial)
cytarabine (cytosar-u) (1 trial)
dactinomycin (cosmegen) (1 trial)
docetaxel (taxotere) (13 trials)
doxorubicin (Doxil) (10 trials)
epirubicin (ellence) (2 trials)
etoposide (vepesid) (4 trials)
gemcitabine (gemzar) (9 trials)
granisetron (kytril) (1 trial)
human fibrin (Tisseel) (1 trial)
ibrutinib (imbruvica) (5 trials)
melphalan (alkeran) (3 trials)
methylprednisolone (medrol) (1 trial)
metoclopramide (reglan) (1 trial)
acalabrutinib (calquence) (1 trial)
anti-egfr immunoliposomes loaded with doxorubicin (1 trial)
atezolizumab (Tecentriq) (2 trials)
azacitidine (vidaza) (1 trial)
bicalutamide (casodex) (1 trial)
bortezomib (velcade) (3 trials)
darolutamide (Nubeqa) (1 trial)
durvalumab (imfinzi) (5 trials)
enzalutamide (xtandi) (1 trial)
erlotinib (tarceva) (2 trials)
everolimus (zortress) (4 trials)
exemestane (aromasin) (1 trial)
lenalidomide (revlimid) (3 trials)
lurbinectedin (Zepzelca) (1 trial)
midostaurin (rydapt) (1 trial)
mirabegron (myrbetriq) (1 trial)
nelfinavir (viracept) (3 trials)
oxaliplatin (eloxatin) (3 trials)
panitumumab (vectibix) (1 trial)
Adenocarcinoma (Phase 3)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Cholangiocarcinoma (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Esophageal Neoplasms (Phase 3)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Stromal Tumors (Phase 2)
Hand-Foot Syndrome (Phase 3)
Head and Neck Neoplasms (Phase 3)
Inflammatory Breast Neoplasms (Phase 3)
Leukemia (Phase 3)
Leukemia, Hairy Cell (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Melanoma (Phase 2)
Mesothelioma (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2)
Nausea (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 3)
Plasmacytoma (Phase 1)
Polycythemia (Phase 2)
Polycythemia Vera (Phase 2)
Preleukemia (Phase 3)
Primary Myelofibrosis (Phase 2)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 2)
Sarcoma (Phase 3)
Seminoma (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 3)
Syndrome (Phase 3)
Testicular Neoplasms (Phase 2)
Thrombocythemia, Essential (Phase 2)
Thrombocytosis (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Vomiting (Phase 3)